| Original language | English |
|---|---|
| Title of host publication | Encyclopedia of Pharmacy Practice and Clinical Pharmacy |
| Editors | Zaheer-Ud-Din Babar, Zubin Austin, Ahmed Awaisu, Timothy Chen, Louise Curley, Danijela Gnjidic, Arijana Meštrović, Kath Ryan |
| Place of Publication | Amsterdam, The Netherlands |
| Publisher | Elsevier |
| Pages | 420-434 |
| Number of pages | 15 |
| Volume | 2 |
| Edition | 1st |
| ISBN (Electronic) | 9780128127353 |
| ISBN (Print) | 9780128127360 |
| DOIs | |
| Publication status | Published - 2019 |
Abstract
Around the world, health policy decision makers and payers are compelled to ensure delivery of quality health care under ever-tighter budgetary constraints and increasing demand. This is due to many factors, including ageing populations, expensive health technologies, and financial uncertainty. Yet, despite all the heterogeneity across different drug markets, a constant fact is that costs and cost-effectiveness are crucial determinants of the feasibility and affordability of pharmacotherapy. This chapter will provide an overview of the different approaches to economic evaluation of pharmacotherapies and describe health technology assessment methods used to outline the process in drug reimbursement.
Keywords
- Cost-benefit
- Cost-effectiveness
- Cost-utility
- Costs
- Economic-evaluations
- Health care
- Health technology assessment
- Incremental cost-effectiveness ratio
- Pharmacotherapy
- Quality of life
